Moderna, Inc.
MRNA
$25.18
$1.124.66%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.11B | 2.96B | 3.03B | 3.11B | 4.96B |
| Total Other Revenue | 121.00M | 120.00M | 149.00M | 127.00M | 117.00M |
| Total Revenue | 2.23B | 3.08B | 3.18B | 3.24B | 5.08B |
| Cost of Revenue | 3.91B | 4.21B | 4.73B | 4.94B | 5.41B |
| Gross Profit | -1.68B | -1.13B | -1.55B | -1.70B | -332.00M |
| SG&A Expenses | 1.06B | 1.07B | 1.11B | 1.17B | 1.29B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.70B | 6.35B | 6.91B | 7.18B | 7.77B |
| Operating Income | -3.46B | -3.27B | -3.73B | -3.95B | -2.69B |
| Income Before Tax | -3.15B | -2.95B | -3.41B | -3.61B | -2.35B |
| Income Tax Expenses | -37.00M | -42.00M | -49.00M | -46.00M | -129.00M |
| Earnings from Continuing Operations | -3.12K | -2.90K | -3.36K | -3.56K | -2.22K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.12B | -2.90B | -3.36B | -3.56B | -2.22B |
| EBIT | -3.46B | -3.27B | -3.73B | -3.95B | -2.69B |
| EBITDA | -3.26B | -3.07B | -3.54B | -3.76B | -2.36B |
| EPS Basic | -8.06 | -7.52 | -8.72 | -9.28 | -5.80 |
| Normalized Basic EPS | -5.08 | -4.73 | -5.45 | -5.78 | -3.73 |
| EPS Diluted | -8.07 | -7.53 | -8.74 | -9.30 | -5.84 |
| Normalized Diluted EPS | -5.08 | -4.73 | -5.45 | -5.79 | -3.73 |
| Average Basic Shares Outstanding | 1.55B | 1.54B | 1.54B | 1.54B | 1.53B |
| Average Diluted Shares Outstanding | 1.55B | 1.56B | 1.55B | 1.55B | 1.56B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |